Romosozumab: confusión respecto a sus indicaciones
González Macías, Jesús; Olmos Martínez, José Manuel.
Rev. osteoporos. metab. miner. (Internet)
; 15(2): 81-87, Abr-Jun 2023.
Artículo en Español | IBECS (España) | ID: ibc-222676
Documentos relacionados
Communicating Absolute Fracture Risk Reduction and the Acceptance of Treatment for Osteoporosis.
Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts.
Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis.
Determining patient preferences for the medical management of osteoporosis using conjoint analysis.
Efficacy of anti-osteoporosis treatment for men with osteoporosis: a meta-analysis.
Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance.
Efficacy of osteoporosis pharmacological treatments in men: a systematic review and meta-analysis.
Health-related quality of life of men with primary osteoporosis and its changes after bisphosphonates treatment.
Evaluation of quality and readability of online patient information on osteoporosis and osteoporosis drug treatment and recommendations for improvement.
Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people.